OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
A Pilot Trial of Thymalfasin (Thymosin-α-1) to Treat Hospitalized Patients With Hypoxemia and Lymphocytopenia Due to Coronavirus Disease 2019 Infection
Fadi Shehadeh, Gregorio Benitez, Evangelia K. Mylona, et al.
The Journal of Infectious Diseases (2022) Vol. 227, Iss. 2, pp. 226-235
Open Access | Times Cited: 9
Fadi Shehadeh, Gregorio Benitez, Evangelia K. Mylona, et al.
The Journal of Infectious Diseases (2022) Vol. 227, Iss. 2, pp. 226-235
Open Access | Times Cited: 9
Showing 9 citing articles:
A pilot trial of Thymalfasin (Ta1) to prevent covid-19 infection and morbidities in renal dialysis patients: Preliminary report
Cynthia Tuthill, Ahmed Awad, M Parrigon, et al.
International Immunopharmacology (2023) Vol. 117, pp. 109950-109950
Open Access | Times Cited: 5
Cynthia Tuthill, Ahmed Awad, M Parrigon, et al.
International Immunopharmacology (2023) Vol. 117, pp. 109950-109950
Open Access | Times Cited: 5
Thymosin alpha1 use in adult COVID-19 patients: A systematic review and meta-analysis on clinical outcomes
Weifeng Shang, Bo Zhang, Yali Ren, et al.
International Immunopharmacology (2022) Vol. 114, pp. 109584-109584
Open Access | Times Cited: 8
Weifeng Shang, Bo Zhang, Yali Ren, et al.
International Immunopharmacology (2022) Vol. 114, pp. 109584-109584
Open Access | Times Cited: 8
Clinical practice of sepsis-induced immunosuppression: Current immunotherapy and future options
Fei Pei, Bin Gu, Shumin Miao, et al.
Chinese Journal of Traumatology (2023) Vol. 27, Iss. 2, pp. 63-70
Open Access | Times Cited: 3
Fei Pei, Bin Gu, Shumin Miao, et al.
Chinese Journal of Traumatology (2023) Vol. 27, Iss. 2, pp. 63-70
Open Access | Times Cited: 3
The use of alpha 1 thymosin as an immunomodulator of the response against SARS-Cov2
María de la Sierra Espinar-Buitrago, Laura Tarancón‐Díez, Elena Vázquez‐Alejo, et al.
Immunity & Ageing (2023) Vol. 20, Iss. 1
Open Access | Times Cited: 2
María de la Sierra Espinar-Buitrago, Laura Tarancón‐Díez, Elena Vázquez‐Alejo, et al.
Immunity & Ageing (2023) Vol. 20, Iss. 1
Open Access | Times Cited: 2
Thymosin α1 modulated the immune landscape of COVID-19 patients revealed by single-cell RNA and TCR sequencing
Han Bai, Liyuan Liang, Xin Qi, et al.
International Immunopharmacology (2023) Vol. 124, pp. 110983-110983
Closed Access | Times Cited: 2
Han Bai, Liyuan Liang, Xin Qi, et al.
International Immunopharmacology (2023) Vol. 124, pp. 110983-110983
Closed Access | Times Cited: 2
The efficacy of thymosin alpha-1 therapy in moderate to critical COVID-19 patients: a systematic review, meta-analysis, and meta-regression
Arto Yuwono Soeroto, Hendarsyah Suryadinata, Theo Audi Yanto, et al.
Inflammopharmacology (2023) Vol. 31, Iss. 6, pp. 3317-3325
Closed Access | Times Cited: 2
Arto Yuwono Soeroto, Hendarsyah Suryadinata, Theo Audi Yanto, et al.
Inflammopharmacology (2023) Vol. 31, Iss. 6, pp. 3317-3325
Closed Access | Times Cited: 2
Phenotypic drug discovery: a case for thymosin alpha-1
Enrico Garaci, Maurizio Paci, Claudia Matteucci, et al.
Frontiers in Medicine (2024) Vol. 11
Open Access
Enrico Garaci, Maurizio Paci, Claudia Matteucci, et al.
Frontiers in Medicine (2024) Vol. 11
Open Access
Expert Consensus on Prevention and Treatment of COVID-19 Infection in Patients with Lung Cancer.
PubMed (2023) Vol. 26, Iss. 3, pp. 165-176
Closed Access
PubMed (2023) Vol. 26, Iss. 3, pp. 165-176
Closed Access
Efficacy of thymosin-α-1 in patients with COVID-19: A systematic review and meta-analysis
Pu Wang, Changhong Wang, Da Chen
European Journal of Inflammation (2023) Vol. 21
Open Access
Pu Wang, Changhong Wang, Da Chen
European Journal of Inflammation (2023) Vol. 21
Open Access
